IN STEALTH MODE NOW - - - Nonagen Therapeutics Corporation is an early-stage biotech company committed to bringing to the market best-in-class therapies designed to target the microenvironment in human cancers. We believe that the lack of a broad and sustained clinical response to angiogenic agents or checkpoint inhibitors is because these therapies only target one component of the TME, whereas a broader, more multi-faceted therapeutic approach is required. Our core technology is based on paradigm shifting discovery of targeting both novel angiogenic and immune molecules. Nonagen is leveraging its deep understanding of tumor microenvironment (TME) biological pathways to target factors and cells that stimulate angiogenesis and suppress patients’ anti-tumor immune response. We push ourselves to develop the next-generation therapies to help patients suffering with cancer. Mission statement - Discover and develop breakthrough therapeutics for human diseases Vision statement - To save lives through innovative research